Analyst Reco. Zimmer Biomet Holdings, Inc. Börse Stuttgart

Equities

ZIM

US98956P1021

Market Closed - Börse Stuttgart Other stock markets 07:44:11 28/06/2024 pm IST			5-day change	1st Jan Change
100.3 ^EUR	-0.10%		-0.30%	-8.28%

20/06	Zimmer Biomet Holdings, Inc. Appoints Devdatt Kurdikar to its Board of Directors	CI
12/06	Zimmer Biomet Enters Co-Marketing Deal With RevelAi Health	MT

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Zimmer Biomet Holdings Insider Sold Shares Worth $1,474,582, According to a Recent SEC Filing	05/06	MT
Barclays Adjusts Price Target on Zimmer Biomet to $125 From $130	31/05	MT
Barclays Adjusts Price Target on Zimmer Biomet Holdings to $125 From $130	31/05	MT
Argus Upgrades Zimmer Biomet to Buy From Hold With $150 Price Target	21/05	MT
Raymond James Adjusts Price Target on Zimmer Biomet Holdings to $138 From $142	03/05	MT
UBS Adjusts Price Target on Zimmer Biomet Holdings to $112 From $109, Maintains Sell Rating	03/05	MT
Truist Adjusts Zimmer Biomet Holdings' PT to $130 From $137, Keeps Hold Rating	03/05	MT
Bernstein Adjusts Price Target on Zimmer Biomet to $133 From $132	03/05	MT
Jefferies Adjusts Price Target on Zimmer Biomet to $135 From $136	03/05	MT
Citigroup Adjusts Price Target on Zimmer Biomet to $134 From $140	03/05	MT
Morgan Stanley Adjusts Price Target on Zimmer Biomet to $130 From $135	03/05	MT
Jefferies Adjusts Zimmer Biomet Price Target to $135 From $136	03/05	MT
Citigroup Adjusts Zimmer Biomet Price Target to $134 From $140	03/05	MT
Morgan Stanley Adjusts Zimmer Biomet Price Target to $130 From $135	03/05	MT
Oppenheimer Adjusts Price Target on Zimmer Biomet Holdings to $155 From $150	03/05	MT
BTIG Adjusts Price Target on Zimmer Biomet to $139 From $138, Keeps Buy Rating	02/05	MT
Truist Securities Adjusts Zimmer Biomet Price Target to $137 From $135, Hold Rating Kept	15/04	MT
Citigroup Raises Price Target on Zimmer Biomet to $140 From $134, Keeps Neutral Rating	03/04	MT
UBS Adjusts Zimmer Biomet Price Target to $109 From $105, Maintains Sell Rating	09/02	MT
Deutsche Bank Adjusts Zimmer Biomet Price Target to $140 From $147, Maintains Hold Rating	09/02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Zimmer Biomet Holdings, Inc. Börse Stuttgart

Equities

ZIM

US98956P1021

Analyst Reco.

Filters